Regulated Proteolytic Processing of Reelin through Interplay of Tissue Plasminogen Activator (tPA), ADAMTS-4, ADAMTS-5, and Their Modulators

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Krstic, Dimitrije ^a   Rodriguez, Myriam ^a   Knuesel, Irene ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 1; AGGRECANASE 2; ALPHA 2 MACROGLOBULIN; REELIN; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ADAM PROTEINS; ANIMALS; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HEK293 CELLS; HELA CELLS; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEOLYSIS; SERINE ENDOPEPTIDASES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84867628829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047793     Document Type: Article

References (63)

1. Tissir F, Lambert de Rouvroit C, Goffinet AM, (2002) The role of reelin in the development and evolution of the cerebral cortex. Braz J Med Biol Res 35: 1473-1484.
2. Nomura T, Takahashi M, Hara Y, Osumi N, (2008) Patterns of neurogenesis and amplitude of Reelin expression are essential for making a mammalian-type cortex. PLoS One 3: e1454.
3. Tissir F, Goffinet AM, (2003) Reelin and brain development. Nat Rev Neurosci 4: 496-505.
4. Förster E, Bock HH, Herz J, Chai X, Frotscher M, et al. (2010) Emerging topics in Reelin function. Eur J Neurosci 31: 1511-1518.
5. Herz J, Chen Y, (2006) Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 7: 850-859.
6. Rogers JT, Weeber EJ, (2008) Reelin and apoE actions on signal transduction, synaptic function and memory formation. Neuron Glia Biol 4: 259-270.
7. Fatemi SH, Kroll JL, Stary JM, (2001) Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 12: 3209-3215.
8. Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, et al. (2005) Reelin signaling is impaired in autism. Biol. Psychiatry 57: 777-787.
9. Botella-López A, Burgaya F, Gavín R, García-Ayllón MS, Gómez-Tortosa E, et al. (2006) Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc Natl Acad Sci U S A 103: 5573-5578.
10. Botella-López A, Cuchillo-Ibáñez I, Cotrufo T, Mok SS, Li QX, et al. (2010) Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease. Neurobiol Dis 37: 682-691.
11. Herring A, Donath A, Steiner KM, Widera MP, Hamzehian S, et al. (2012) Reelin Depletion is an Early Phenomenon of Alzheimer's Pathology. J Alzheimers Dis 30: 963-979.
12. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, et al. (1999) Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97: 689-701.
13. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, et al. (1999) Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24: 481-489.
14. Strasser V, Fasching D, Hauser C, Mayer H, Bock HH, et al. (2004) Receptor clustering is involved in Reelin signaling. Mol Cell Biol 24: 1378-1386.
15. Bock HH, Jossin Y, Liu P, Förster E, May P, et al. (2003) Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem 278: 38772-38779.
16. Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, et al. (2002) Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem 277: 49958-49964.
17. Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, et al. (2003) Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J 17: 295-297.
18. Lambert de Rouvroit C, de Bergeyck V, Cortvrindt C, Bar I, Eeckhout Y, et al. (1999) Reelin, the extracellular matrix protein deficient in reeler mutant mice, is processed by a metalloproteinase. Exp Neurol 156: 214-217.
19. Kohno S, Kohno T, Nakano Y, Suzuki K, Ishii M, et al. (2009) Mechanism and significance of specific proteolytic cleavage of Reelin. Biochem Biophys Res Commun 380: 93-97.
20. Kubo K, Mikoshiba K, Nakajima K, (2002) Secreted Reelin molecules form homodimers. Neurosci Res 43: 381-388.
21. Jossin Y, Ignatova N, Hiesberger T, Herz J, Lambert de Rouvroit C, et al. (2004) The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development. J Neurosci 24: 514-521.
22. Jossin Y, Gui L, Goffinet AM, (2007) Processing of Reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons. J Neurosci 27: 4243-4252.
23. Yasui N, Kitago Y, Beppu A, Kohno T, Morishita S, et al. (2011) Functional importance of covalent homodimer of reelin protein linked via its central region. J Biol Chem 286: 35247-35256.
24. Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW, (2006) DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J Biol Chem 281: 35176-35185.
25. Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, et al. (2009) Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 29: 7459-7473.
26. de Bergeyck V, Nakajima K, Lambert de Rouvroit C, Naerhuyzen B, Goffinet AM, et al. (1997) A truncated Reelin protein is produced but not secreted in the 'Orleans' reeler mutation (Reln[rl-Orl]). Brain Res Mol Brain Res 50: 85-90.
27. Nakano Y, Kohno T, Hibi T, Kohno S, Baba A, et al. (2007) The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling. J Biol Chem 282: 20544-20552.
28. Kohno T, Nakano Y, Kitoh N, Yagi H, Kato K, et al. (2009) C-terminal region-dependent change of antibody-binding to the Eighth Reelin repeat reflects the signaling activity of Reelin. J Neurosci Res 87: 3043-3053.
29. Utsunomiya-Tate N, Kubo K, Tate S, Kainosho M, Katayama E, et al. (2000) Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc Natl Acad Sci U S A 97: 9729-9734.
30. Knuesel I, Nyffeler M, Mormède C, Muhia M, Meyer U, et al. (2009) Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol Aging 30: 697-716.
31. Fatemi SH, (2005) Reelin glycoprotein: structure, biology and roles in health and disease. Mol Psychiatry 10: 251-257.
32. Knuesel I, (2010) Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog Neurobiol 91: 257-274.
33. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
34. Ducharme P, Maltais D, Desroches D, Mateescu MA, Paquin J, (2010) Ceruloplasmin-induced aggregation of P19 neurons involves a serine protease activity and is accompanied by reelin cleavage. Neuroscience 167: 633-643.
35. Hatada I, Morita S, Kimura M, Horii T, Yamashita R, et al. (2008) Genome-wide demethylation during neural differentiation of P19 embryonal carcinoma cells. J Hum Genet 53: 185-191.
36. Lugli G, Krueger JM, Davis JM, Persico AM, Keller F, et al. (2003) Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochem 4: 9.
37. Zeng W, Corcoran C, Collins-Racie LA, Lavallie ER, Morris EA, et al. (2006) Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5,-9,-16 and-18. Biochim Biophys Acta 1760: 517-524.
38. Vankemmelbeke MN, Jones GC, Fowles C, Ilic MZ, Handley CJ, et al. (2003) Selective inhibition of ADAMTS-1,-4 and-5 by catechin gallate esters. Eur J Biochem 270: 2394-403.
39. Pratta MA, Scherle PA, Yang G, Liu RQ, Newton RC, (2003) Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. Arthritis Rheum48: 119-133.
40. Wågsäter D, Björk H, Zhu C, Björkegren J, Valen G, et al. (2008) ADAMTS-4 and-8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 196: 514-522.
41. Lauer-Fields JL, Spicer TP, Chase PS, Cudic M, Burstein GD, et al. (2008) Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate. Anal Biochem 373: 43-51.
42. Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y, (2001) Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett 494: 192-195.
43. Tortorella MD, Arner EC, Hills R, Easton A, Korte-Sarfaty J, et al. (2004) Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem 279: 17554-17561.
44. Tortorella MD, Arner EC, Hills R, Gormley J, Fok K, et al. (2005) ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms. Arch Biochem Biophys 444: 34-44.
45. Wang P, Tortorella M, England K, Malfait AM, Thomas G, et al. (2004) Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J Biol Chem 279: 15434-15440.
46. Fosang AJ, Rogerson FM, East CJ, Stanton H, (2008) ADAMTS-5: the story so far. Eur Cell Mater 15: 11-26.
47. Tortorella MD, Malfait AM, (2008) Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis. Curr Pharm Biotechnol 9: 16-23.
48. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S, (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17: 543-552.
49. Salles FJ, Strickland S, (2002) Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci 22: 2125-2134.
50. Doehner J, Madhusudan A, Konietzko U, Fritschy JM, Knuesel I, (2010) Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice. J Alzheimers Dis 19: 1339-1357.
51. Pittman RN, Ivins JK, Buettner HM, (1989) Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth. J Neurosci 9: 4269-4286.
52. Doehner J, Genoud C, Imhof C, Krstic D, Knuesel I, (2012) Extrusion of misfolded and aggregated proteins- a protective strategy of aging neurons? Eur J Neurosci 35: 1938-1950.
53. Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, et al. (2010) Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J Neurosci 30: 9228-9240.
54. Martinez-Vicente M, Sovak G, Cuervo AM, (2005) Protein degradation and aging. Exp Gerontol 40: 622-633.
55. Hibi T, Hattori M, (2009) The N-terminal fragment of Reelin is generated after endocytosis and released through the pathway regulated by Rab11. FEBS Lett 583: 1299-1303.
56. Duveau V, Madhusudan A, Caleo M, Knuesel I, Fritschy JM, (2011) Impaired reelin processing and secretion by Cajal-Retzius cells contributes to granule cell dispersion in a mouse model of temporal lobe epilepsy. Hippocampus 21: 935-944.
57. D'Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, et al. (1997) Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J Neurosci 17: 23-31.
58. Medina MG, Ledesma MD, Domínguez JE, Medina M, Zafra D, et al. (2005) Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation. EMBO J 24: 1706-1716.
59. Lee JY, Kweon HS, Cho E, Lee JY, Byun HR, et al. (2007) Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease. Neurosci Lett 423: 82-87.
60. Weaver MS, Workman G, Cardo-Vila M, Arap W, Pasqualini R, et al. (2010) Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4. J Biol Chem 285: 5868-5877.
61. Dupuis LE, McCulloch DR, McGarity JD, Bahan A, Wessels A, et al. (2011) Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. Dev Biol 357: 152-164.
62. McCulloch DR, Le Goff C, Bhatt S, Dixon LJ, Sandy JD, et al. (2009) Adamts5, the gene encoding a proteoglycan-degrading metalloprotease, is expressed by specific cell lineages during mouse embryonic development and in adult tissues. Gene Expr Patterns 9: 314-323.
63. Yuan W, Matthews RT, Sandy JD, Gottschall PE, (2002) Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 114: 1091-1101.